Hjem › Hidradenitis suppurativa › Texas
Kliniske studier for Hidradenitis suppurativa i Texas
8 studier for Hidradenitis suppurativa søker deltakere på steder i Texas.
Byer i Texas
Offisiell studietekst (engelsk)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Center for Clinical Studies-Lee, Webster
RekruttererFase 3
Alder 18 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Dallas
- Oruka Therapeutics Investigative Site, Missouri City
- Oruka Therapeutics Investigative Site, San Antonio
RekruttererFase 2
Alder 18 til 79 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Elligo Health Research/The Woodlands Dermatology Associates- Site Number : 8400020, The Woodlands
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US021, Bellaire
- Investigative Site US078, Dallas
- Investigative Site US010, Dallas
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06855498Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- UT Southwestern Medical Center, Department of Dermatology- Site Number : 8400022, Dallas
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07170917Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Bellaire Dermatology Associates Bda, Bellaire
- Texas Dermatology Research Center, Dallas
- 3A Research Llc West Location, El Paso
RekruttererFase 2
Alder 12 til 17 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07213973A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- The University of Texas MD Anderson Cancer Center, Houston
RekruttererObservasjonsstudie
Alder 18 til 71 · Alle kjønn · Oppdatert 16. apr. 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Arlington Research Center, Inc., Arlington
- Texas Dermatology Research Center, Dallas
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mar. 2026 · NCT07244263Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.